Suppr超能文献

甲状腺疾病中血浆纤连蛋白水平的变化。

Changes in plasma fibronectin levels in thyroid diseases.

作者信息

Shirakami A, Hirai Y, Takeichi T, Nishino H, Inomoto T, Watanabe S, Shigekiyo T, Kawauchi S, Saito H, Saito S

出版信息

Horm Metab Res. 1986 May;18(5):345-8. doi: 10.1055/s-2007-1012311.

Abstract

The plasma levels of fibronectin (Fn) have been measured in normal subjects and in patients with thyroid diseases. The mean plasma Fn levels in 62 normal adults was 32.0 +/- 6.0 mg/dl, whereas it was elevated to 62.6 +/- 16.1 mg/dl (mean +/- SD) in 25 patients with hyperthyroidism and decreased to 19.2 +/- 8.0 mg/dl in 9 patients with hypothyroidism. The 9 patients with simple goiter have normal values of 29.1 +/- 8.0 mg/dl. With the administration of anti-thyroid drugs, plasma Fn levels normalized, with a time lag, in parallel with normalization of the thyroid function. Positive correlation was obtained between Fn levels and serum levels of triiodothyronine (T3) and thyroxine (T4). The present findings indicate that measurement of plasma Fn both in the basal state and during treatment provides evidence of altered Fn metabolism in thyroid diseases and serves to follow up the effect of treatment.

摘要

已对正常受试者和甲状腺疾病患者的血浆纤连蛋白(Fn)水平进行了测量。62名正常成年人的血浆Fn平均水平为32.0±6.0mg/dl,而25名甲状腺功能亢进患者的血浆Fn水平升高至62.6±16.1mg/dl(平均值±标准差),9名甲状腺功能减退患者的血浆Fn水平降至19.2±8.0mg/dl。9名单纯性甲状腺肿患者的Fn值正常,为29.1±8.0mg/dl。随着抗甲状腺药物的使用,血浆Fn水平会随甲状腺功能的恢复正常而出现延迟性恢复正常。Fn水平与血清三碘甲状腺原氨酸(T3)和甲状腺素(T4)水平之间存在正相关。目前的研究结果表明,在基础状态和治疗期间测量血浆Fn可为甲状腺疾病中Fn代谢改变提供证据,并有助于随访治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验